Its cofactors are TPP bound to E1, lipoic acid covalently bound to lysine on E2 which accepts the hydroxyethyl carbanion from TPP as an acetyl group, coenzyme A which is substrate for E2 and accepts the acetyl group from it, FAD bound to the E3 subunit reduced by lipoamide and NAD which is substrate for E3 and reduced by FADH2 [64]
Weight tracking
Disease is a critical disease and not complying to the prescribed dosage can have negative health effects and the drug will not show the intended treatment as well as it should
In India, even at an early stage: Mounjaro (tirzepatide) is seeing stronger demand than Ozempic and Wegovy combined
Clinical studies have shown that patients taking tirzepatide not only experienced better glycemic control but also lost a notable amount of weight compared to those on traditional diabetes medications
Altay O, Arif M, Li X, Yang H, Aydn M, Alkurt G, et al